PTC Therapeutics
PTCT
#3055
Rank
ยฃ3.94 B
Marketcap
ยฃ47.25
Share price
-1.06%
Change (1 day)
-2.50%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of June 2026 : -ยฃ0.13 Billion

According to PTC Therapeutics 's latest financial reports the company has -ยฃ0.13 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-ยฃ0.16 Billion-82.58%
2024-12-31$-ยฃ0.88 Billion36.19%
2023-12-31$-ยฃ0.65 Billion123.95%
2022-12-31$-ยฃ0.29 Billion-27030.61%
2021-12-31$ยฃ1.06 M-99.7%
2020-12-31$ยฃ0.35 B-21.98%
2019-12-31$ยฃ0.45 B64.04%
2018-12-31$ยฃ0.27 B138.71%
2017-12-31$ยฃ0.11 B19.44%
2016-12-31$ยฃ96.91 M-36.45%
2015-12-31$ยฃ0.15 B-20.45%
2014-12-31$ยฃ0.19 B131.59%
2013-12-31$ยฃ82.77 M-797.03%
2012-12-31$-ยฃ11.88 Million-92.26%
2011-12-31$-ยฃ0.16 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
ยฃ31.68 B-25,466.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
ยฃ15.29 B-12,344.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.38 B-404.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.15 B-1,023.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
ยฃ0.11 B-192.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
ยฃ1.27 B-1,121.15%๐Ÿ‡บ๐Ÿ‡ธ USA